BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
2811465
Number of visits today
547
Number of downloads
2062933
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Tefas LR, Barbălată C, Tefas C, Tomuță I. Salinomycin-Based Drug Delivery Systems: Overcoming the Hurdles in Cancer Therapy. Pharmaceutics 2021;13:1120. [PMID: 34452081 DOI: 10.3390/pharmaceutics13081120] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Anees M, Mehrotra N, Tiwari S, Kumar D, Kharbanda S, Singh H. Polylactic acid based biodegradable hybrid block copolymeric nanoparticle mediated co-delivery of salinomycin and doxorubicin for cancer therapy. Int J Pharm 2023;635:122779. [PMID: 36842520 DOI: 10.1016/j.ijpharm.2023.122779] [Reference Citation Analysis]
2 Tefas LR, Toma I, Sesarman A, Banciu M, Jurj A, Berindan-neagoe I, Rus L, Stiufiuc R, Tomuta I. Co-delivery of gemcitabine and salinomycin in PEGylated liposomes for enhanced anticancer efficacy against colorectal cancer. Journal of Liposome Research 2022. [DOI: 10.1080/08982104.2022.2153139] [Reference Citation Analysis]
3 Nayak A, Warrier NM, Kumar P. Cancer Stem Cells and the Tumor Microenvironment: Targeting the Critical Crosstalk through Nanocarrier Systems. Stem Cell Rev Rep 2022. [PMID: 35876959 DOI: 10.1007/s12015-022-10426-9] [Reference Citation Analysis]
4 Contreras-torres FF, Salas-treviño D, Soto-domínguez A, De Jesús García-rivas G. Carbon Nanotubes in Tumor-Targeted Chemotherapeutic Formulations: A Review of Opportunities and Challenges. ACS Appl Nano Mater . [DOI: 10.1021/acsanm.2c01118] [Reference Citation Analysis]
5 Chai AWY, Tan AC, Cheong SC. Uncovering drug repurposing candidates for head and neck cancers: insights from systematic pharmacogenomics data analysis. Sci Rep 2021;11:23933. [PMID: 34907286 DOI: 10.1038/s41598-021-03418-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345